SCHEMBL4669308

SCHEMBL4669308

COCCCCC1(CNC(=O)C2CCCN(C(=O)OC(C)(C)C)C2)c2ccccc2Oc2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REN P00797 3/20 0.64
HSD11B1 P28845 1/20 0.41
USP30 Q70CQ3 1/20 0.40
KDM1A O60341 1/20 0.40
ACKR3 P25106 1/20 0.39
KDM4E B2RXH2 2/20 0.39
PKM P14618 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
GAA P10253 2/20 0.38
TP53 P04637 1/20 0.38
THRB P10828 1/20 0.38
NPC1 O15118 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
ITGB3 P05106 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4912890 0.87 REN (0.57) RENHSD11B1USP30KDM1AKDM4E
SCHEMBL4669434 0.87 REN (0.57) RENUSP30KDM4EPKMMAPT
SCHEMBL4669437 0.87 REN (0.57) RENUSP30KDM4EPKMMAPT
SCHEMBL4667631 0.87 REN (0.57) RENUSP30KDM4EPKMMAPT
SCHEMBL4670533 0.87 REN (0.57) RENHSD11B1USP30KDM1AKDM4E
SCHEMBL4912885 0.87 REN (0.57) RENHSD11B1USP30KDM1AKDM4E
SCHEMBL4670528 0.87 REN (0.47) RENHSD11B1USP30KDM1AACKR3
SCHEMBL4902242 0.87 REN (0.55) RENHSD11B1USP30KDM4EPKM
SCHEMBL4902246 0.87 REN (0.55) RENHSD11B1USP30KDM4EPKM
SCHEMBL4903306 0.87 REN (0.55) RENHSD11B1USP30KDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194629-A1 3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors BAESCHLIN DANIEL KASPAR 2008-08-14 US disclosed
EP-1879882-A1 3 -M0N0- AND 3 , 5-DISUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS Novartis AG (CH) 2008-01-23 EP disclosed
WO-2006117183-A1 3 -M0N0- AND 3 , 5-DISUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS NOVARTIS AG (CH) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194629-A1 3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors REN, ACE, AGTR1 REN 1/4885HSD11B1 1567/4885USP30 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.